---
figid: PMC5995256__oncotarget-09-25957-g005
figtitle: Pathways altered in brain metastases compared to primary NSCLC
organisms:
- NA
pmcid: PMC5995256
filename: oncotarget-09-25957-g005.jpg
figlink: /pmc/articles/PMC5995256/figure/F5/
number: F5
caption: (A) the PI3K/AKT and JAK/STAT signaling pathways and (B) the DNA Damage Response
  pathway. Red = gain of function, Blue = loss of function; Gray = inferred normal.
  Entities outlined in red are potential drug targets.
papertitle: Targeted DNA sequencing of non-small cell lung cancer identifies mutations
  associated with brain metastases.
reftext: George D. Wilson, et al. Oncotarget. 2018 May 25;9(40):25957-25970.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.934468
figid_alias: PMC5995256__F5
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5995256__F5
ndex: 164eee97-dec0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5995256__oncotarget-09-25957-g005.html
  '@type': Dataset
  description: (A) the PI3K/AKT and JAK/STAT signaling pathways and (B) the DNA Damage
    Response pathway. Red = gain of function, Blue = loss of function; Gray = inferred
    normal. Entities outlined in red are potential drug targets.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - scb
  - stck
  - Tie
  - Ras85D
  - InR
  - drk
  - Sos
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - hop
  - bsk
  - elB
  - Ilk
  - Pten
  - Shc
  - Pdk1
  - Myb
  - Taf5
  - ras
  - Ras64B
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - mir-ban
  - kk
  - Dif
  - dl
  - Rel
  - Cdc37
  - Tsc1
  - Nos
  - nos
  - foxo
  - cass
  - 14-3-3zeta
  - 14-3-3epsilon
  - Aplip1
  - dap
  - gig
  - Dsor1
  - Mtk
  - ecl
  - ecp
  - Rheb
  - Erk7
  - rl
  - arm
  - GlyS
  - tor
  - Tor
  - Egfr
  - WDR79
  - tral
  - rump
  - MED17
  - SF1
  - Irbp
  - Thor
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - CycE
  - cyc
  - p53
  - betaTub60D
  - hth
  - LIMS1
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - S100A10
  - EXOSC3
  - ILK
  - INPP5D
  - PTEN
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - A1BG
  - PDK1
  - PDPK1
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - KRAS
  - HRAS
  - NRAS
  - THEM4
  - PTPA
  - MAP3K8
  - CROT
  - NFKB1
  - MCL1
  - CDC37
  - TSC1
  - CCL26
  - NOS1
  - NOS2
  - NOS3
  - FOXO1
  - BAD
  - YWHAQ
  - MAPK8IP1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - ATP5F1A
  - SLC12A9
  - TSC2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CCL21
  - RHEB
  - RHEBP1
  - EPHB2
  - MAPK1
  - MAPK3
  - CTNNB1
  - CND
  - NANOG
  - GDF15
  - GYS1
  - GYS2
  - RORC
  - ANXA6
  - UBASH3B
  - EIF4EBP1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - EIF4E
  - EIF4E2
  - EIF4E3
  - TP53
  - TP63
  - TP73
  - PIP3<-PIP2
  - PINCH PIP3< PIP2 PIP3
  - Tanespimycin
  - targinine
  - NANOG
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
